Price $2.65 |
Market Cap
207.9M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
59.0
|
P/B
3.4
|
P/S
0.57
|
Dividend %
-
|
|
P/CF
9.9
|
P/FCF
-
|
Op. Cash Flow
-1.5K
|
FCF
0.0
|
|
Op. Margin
3.30%
|
Net Margin
1.00%
|
ROE
6.90%
|
ROI
9.30%
|
|
ROA
0.80%
|
EPS Growth
122.00%
|
Current Ratio
2.0
|
Debt/Equity
297.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Aerpio Pharmaceuticals Inc (ARPO) | $1.50 | - | - | 58.1M | Strong Buy |
| China SXT Pharmaceuticals Inc (SXTC) | $0.24 | - | - | 19.6M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $2.94 | - | - | 70.1M | Strong Buy |
| IRIDEX Corporation (IRIX) | $1.96 | - | - | 28.1M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.39 | - | - | 54.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
